title: [The new effective anticestodian agent fluxane].
authors.forename: S N
authors.initials: SN
authors.lastname: Trusov
authors.forename: F S
authors.initials: FS
authors.lastname: Mikhaĭlitsyn
authors.forename: D P
authors.initials: DP
authors.lastname: Sevbo
authors.forename: I A
authors.initials: IA
authors.lastname: Arkhipov
authors.forename: E I
authors.initials: EI
authors.lastname: Koveshnikova
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000923:Anticestodal Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D001549:Benzamides / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D052160:Benzothiazoles / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D002589:Cestoda / Q000187:drug effects*; D004353:Drug Evaluation, Preclinical; D006925:Hymenolepiasis / Q000188:drug therapy*; D048189:Hymenolepis nana; D051379:Mice; D008989:Monieziasis / Q000188:drug therapy*; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy*
chemical_list: D000923:Anticestodal Agents; D001549:Benzamides; D052160:Benzothiazoles; C512400:N-(((2-benzothiazolyl)thio)-5-(trifluoromethyl)phenyl)-2-hydroxy-3,5-dibromobenzamide